共查询到20条相似文献,搜索用时 968 毫秒
1.
《Journal of medical economics》2013,16(7):550-563
Abstract
Background:
Asthma and chronic obstructive pulmonary disease (COPD) are incurable diseases that impact quality-of-life. 相似文献2.
《Journal of medical economics》2013,16(8):637-645
Abstract
Objective:
Conduct a cost effectiveness analysis for the Paliperidone palmitate Research In Demonstrating Effectiveness (PRIDE) trial. 相似文献3.
《Journal of medical economics》2013,16(2):202-212
Abstract
Objective:
To estimate the cost-effectiveness of ipilimumab (3?mg/kg) compared with best supportive care (BSC) in pre-treated advanced melanoma patients. 相似文献4.
《Journal of medical economics》2013,16(11):898-908
Abstract
Objective:
To compare healthcare resource utilization (HCRU) and healthcare costs in patients with acute coronary syndrome (ACS) managed with percutaneous coronary intervention (PCI) and treated with prasugrel or ticagrelor. 相似文献5.
《Journal of medical economics》2013,16(6):410-419
Abstract
Objectives:
To project the cost-effectiveness of population-based echo screening to prevent rheumatic heart disease (RHD) consequences. 相似文献6.
《Journal of medical economics》2013,16(2):231-239
Abstract
Objective:
To compare hospitalizations and incidence of relapses among patients with schizophrenia initiating long-acting injectable (LAI) antipsychotics vs oral antipsychotics. 相似文献7.
《Journal of medical economics》2013,16(1):179-189
Abstract
Objective
This retrospective observational study describes treatment patterns and longitudinal health-related quality-of-life (HRQoL) among metastatic breast cancer patients with bone metastasis from nine community oncology clinics. 相似文献8.
《Journal of medical economics》2013,16(5):349-356
Abstract
Objective:
To estimate direct medical costs for patients with tuberous sclerosis complex (TSC) and surgical resection of subependymal giant-cell astrocytoma (SEGA). 相似文献9.
《Journal of medical economics》2013,16(2):298-306
Abstract
Objectives:
To assess factors associated with adherence to phosphodiesterase type 5 inhibitors (PDE5Is) in the management of pulmonary arterial hypertension (PAH). 相似文献10.
《Journal of medical economics》2013,16(9):704-710
Abstract
Objective:
To explore the effect of age and sex on cost of all-cause and multiple sclerosis (MS)-related inpatient facility encounters. 相似文献11.
《Journal of medical economics》2013,16(12):1020-1028
Abstract
Objective:
This study estimated the economic burden of obesity-related comorbidities (ORCs) in the US, at both the person and population levels. 相似文献12.
《Journal of medical economics》2013,16(6):420-432
Abstract
Objective:
To identify the direct and indirect costs of hypoglycemia in patients with Type 1 or Type 2 diabetes mellitus (DM) in the US setting. 相似文献13.
《Journal of medical economics》2013,16(11):974-989
Abstract
Objective:
To estimate cost-effectiveness of exenatide twice daily (BID) vs insulin glargine once daily (QD) as add-on therapy in Chinese type 2 diabetes patients not well controlled by oral anti-diabetic (OAD) agents. 相似文献14.
《Journal of medical economics》2013,16(12):1041-1049
Abstract
Background:
Atrial fibrillation (AF) is the most common cardiac rhythm disturbance in the US, with an estimated prevalence of 2.7–6.1 million persons in 2010. 相似文献15.
《Journal of medical economics》2013,16(5):357-365
Abstract
Objective:
This study aimed to compare real world healthcare costs and resource utilization between patients with schizophrenia treated with paliperidone palmitate long-acting injection (PP) and oral atypical antipsychotics (OAT). 相似文献16.
《Journal of medical economics》2013,16(2):307-317
Abstract
Objective:
To evaluate costs and outcomes associated with initial tapentadol ER vs oxycodone CR for the treatment of chronic non-cancer pain (CNCP) in the US. 相似文献17.
《Journal of medical economics》2013,16(2):213-220
Abstract
Objective:
To assess predictors of achievement of 80% Medication Possession Ratio (MPR) in patients receiving manufacturer-provided self-management services for relapsing-remitting multiple sclerosis (RRMS) patients taking glatiramer acetate (Copaxone). 相似文献18.
《Journal of medical economics》2013,16(2):249-259
Abstract
Objective:
To evaluate the financial consequences of using laparoscopic adjustable gastric banding (LAGB) in place of standard medical management (SMM) in obese patients with type 2 diabetes from a UK healthcare payer perspective. 相似文献19.
《Journal of medical economics》2013,16(11):919-929
Abstract
Objective:
Selective serotonin re-uptake inhibitors (SSRIs) are widely prescribed antidepressants. This claims database study compared healthcare resource use and costs among patients with major depressive disorder (MDD) treated with vilazodone vs other SSRIs. 相似文献20.
《Journal of medical economics》2013,16(6):447-456
Abstract